Topical JAK Inhibitor Active in Atopic Dermatitis

(MedPage Today) -- Significant improvement in multiple endpoints after 4 weeks with ruxolitinib cream

Source: MedPage Today Dermatology - September 14, 2018 Category: Dermatology Source Type: news